Buy Loxitane (Loxapine Succinate) antipsychotic medication
Cheap qualitative Loxapine 10 mg, 25 mg capsules online
HOW AND WHERE TO BUY LOXAPINE (LOXITANE) 10 MG, 25 MG CAPSULES OR TABLETS ONLINE:
Loxitane (Loxapine) should be used with extreme caution in patients with a history of convulsive disorders since it lowers the convulsive threshold. Seizures have been reported in patients receiving this medicine at antipsychotic dose levels, and may occur in epileptic patients even with maintenance of routine anticonvulsant drug therapy.
Loxapine Succinate (Loxitane) has an antiemetic effect in animals. Since this effect may also occur in man, this medication may mask signs of overdosage of toxic drugs and may obscure conditions such as intestinal obstruction and brain tumor.
Loxapine (Loxitane) should be used with caution in patients with cardiovascular disease. Increased pulse rates have been reported in the majority of patients receiving antipsychotic doses; transient hypotension has been reported. In the presence of severe hypotension requiring vasopressor therapy, the preferred drugs may be norepinephrine or angiotensin. Usual doses of epinephrine may be ineffective because of inhibition of its vasopressor effect by Loxitane.
The possibility of ocular toxicity from loxapine cannot be excluded at this time. Therefore, careful observation should be made for pigmentary retinopathy and lenticular pigmentation since these have been observed in some patients receiving certain other antipsychotic drugs for prolonged periods.
Because of possible anticholinergic action, the drug should be used cautiously in patients with glaucoma or a tendency to urinary retention, particularly with concomitant administration of anticholinergic-type antiparkinson medication.
Experience to date indicates the possibility of a slightly higher incidence of extrapyramidal effects following intramuscular administration than normally anticipated with oral formulations. The increase may be attributable to higher plasma levels following intramuscular injection.
Antipsychotic drugs elevate prolactin levels; the elevation persists during chronic administration. Tissue culture experiments indicate that approximately one-third of human breast cancers are prolactin-dependent in vitro, a factor of potential importance if the prescription of these drugs is contemplated in a patient with a previously detected breast cancer. Although disturbances such as galactorrhea, amenorrhea, gynecomastia, and impotence have been reported, the clinical significance of elevated serum prolactin levels is unknown for most patients. An increase in mammary neoplasms has been found in rodents after chronic administration of antipsychotic drugs. Neither clinical studies nor epidemiologic studies conducted to date, however, have shown an association between chronic administration of these drugs and mammary tumorigenesis; the available evidence is considered too limited to be conclusive at this time.
Information for Patients
Given the likelihood that some patients exposed chronically to antipsychotics will develop tardive dyskinesia, it is advised that all patients in whom chronic use is contemplated be given, if possible, full information about this risk. The decision to inform patients and/or their guardians must obviously take into account the clinical circumstances and the competency of the patient to understand the information provided.
There have been rare reports of significant respiratory depression, stupor and/or hypotension with the concomitant use of loxapine and lorazapam.
The risk of using loxapine in combination with CNS-active drugs has not been systematically evaluated. Therefore, caution is advised if the concomitant administration of loxapine and CNSactive drugs is required.
Usage in Pregnancy
Safe use of Loxitane (Loxapine Succinate) during pregnancy or lactation has not been established; therefore, its use in pregnancy, in nursing mothers, or in women of childbearing potential requires that the benefits of treatment be weighed against the possible risks to mother and child. No embryotoxicity or teratogenicity was observed in studies in rats, rabbits, or dogs although, with the exception of one rabbit study, the highest dosage was only two times the maximum recommended human dosage and in some studies it was below this dose. Perinatal studies have shown renal papillary abnormalities in offspring of rats treated from mid-pregnancy with doses of 0.6 and 1.8 mg / kg, doses which approximate the usual human dose but which are considerably below the maximum recommended human dose.
The extent of the excretion of Loxitane (Loxapine) or its metabolites in human milk is not known. However, Loxapine Succinate (Loxitane) and its metabolites have been shown to be transported into the milk of lactating dogs. This drug administration to nursing women should be avoided if clinically possible.
Safety and effectiveness of Loxapine Succinate (Loxitane) in pediatric patients have not been established.
Loxitane (Loxapine) related pharmaceutical drugs and medications
|Trade name of the drug
||Pharmaceutical forms and doses
|Ridazin - Thioridazine Hydrochloride
||Tablets; Oral; Thioridazine Hydrochloride 10 mgTablets; Oral; Thioridazine Hydrochloride 25 mgTablets; Oral; Thioridazine Hydrochloride 50 mgTablets; Oral; Thioridazine Hydrochloride 100 mg
||Taro Pharmaceutical Industries
|Solian precautions - Amisulpride
||Solution; Oral; Amisulpride 100 mg / ml
Buy Loxitane (Loxapine) Online
Loxitane prescribing information
Copyright © Buy Loxapine Online